|1.||Xu, Qiang: 3 articles (10/2015 - 06/2004)|
|2.||Tan, Renxiang: 2 articles (10/2015 - 06/2004)|
|3.||Tan, Ren-Xiang: 2 articles (04/2006 - 09/2005)|
|4.||Guo, Wenjie: 1 article (10/2015)|
|5.||Zhang, Wenjing: 1 article (10/2015)|
|6.||Ren, Ren: 1 article (10/2015)|
|7.||Jiao, Ruihua: 1 article (10/2015)|
|8.||Elgehama, Ahmed: 1 article (10/2015)|
|9.||Wang, Xinlei: 1 article (10/2015)|
|10.||Sun, Yang: 1 article (10/2015)|
09/01/2005 - "In the present paper, the effect of Fumigaclavine C, a fungal metabolite, on experimental colitis was examined. "
09/01/2005 - "Fumigaclavine C, an fungal metabolite, improves experimental colitis in mice via downregulating Th1 cytokine production and matrix metalloproteinase activity."
09/01/2005 - "Fumigaclavine C, when administered intraperitoneally once a day, significantly reduced the weight loss and mortality rate of mice with experimental colitis induced by intrarectally injection of 2, 4, 6-trinitrobenzene sulfonic acid (TNBS). "
10/01/2015 - "Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition."
10/01/2015 - "In the present study, the effect of Fumigaclavine C, a fungal metabolite, on murine experimental colitis induced by dextran sulfate sodium (DSS) and its possible mechanism were examined in vivo and vitro. "
|2.||Cardiovascular Diseases (Cardiovascular Disease)
05/01/2014 - "Fumigaclavine C activates PPARγ pathway and attenuates atherogenesis in ApoE-deficient mice."
05/01/2014 - "To develop alternative therapeutic strategy that reduces hypercholesterolemia, inflammation and atherosclerosis, we investigate if fumigaclavine C (FC), an indole alkaloid in structure, has anti-atherosclerosis function, and if so, what is the mechanism involved. "
|5.||Weight Loss (Weight Reduction)
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||Apolipoproteins E (ApoE)